Observational studyClinical drug investigation2020

Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database.

Najat J Ziyadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.